Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin Analogues for Advanced HCC (SS-HCC)
NCT00495846Phase 3Completed
- Sponsor
- University of Naples Federico II
- Start
- Apr 2007
- Primary completion
- Apr 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Octreotide long-acting injection, lanreotide in hepatocellular carcinoma (HCC), sponsored by University of Naples Federico II. Started Apr 2007; status: completed.
02
Drugs
Octreotide long-acting injectionlanreotide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00495846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495846.